RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering 
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push 
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect 
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk 
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom 
First Western Ship Transits Strait of Hormuz Since Iran War Began 
Apple Turns 50: From Garage Startup to AI Crossroads 
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 
UPS and Teamsters Reach Agreement to Limit Driver Severance Program 
Britain Courts Anthropic Amid US Defense Department Dispute 
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute 
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 
Toronto, Canada, June 22, 2017 -- The Retail Council of Canada selected I-REMOVE Litramine Fat Binder to receive the 2016 Canadian Grand Prix New Product Award for Health Care–OTC (Over the Counter).
|
||||||||
"The unique and innovative formula in I-REMOVE has been the number one-selling weight management aid in Europe for the last six consecutive years,” said Jean-Philippe Sidaner, vice president of sales for Canada and Mexico. “We’re proud that after only a few months in the Canadian market, we’re helping people lose weight and live a healthier life by eating better, moving more and taking I-REMOVE.”
I-REMOVE is a premium, plant-based supplement clinically shown to deliver up to three times more weight loss than dieting alone. The product was launched by InQpharm North America in 2016 in Canada and the United States.
Now in its 24th year, the Canadian Grand Prix New Product Awards is an annual program that celebrates new products in food, non-food and private-label categories. The awards program provides a unique opportunity for entrants to showcase their new products to a jury of industry experts and be recognized by their peers. Winners are chosen based on innovation, originality and consumer acceptance. The awards encourage new product development, which is vital to the continued growth of Canada’s consumer products industry.
For more media information, please contact the Zaluvida Press Office, [email protected].
About InQpharm
InQpharm is part of the Zaluvida Group, a globally operating life science group that endeavors to rapidly develop solutions for the biggest challenges in healthcare. The company is led from its corporate offices in Switzerland and has branches in Germany, Wales, the Netherlands, the U.S., and Malaysia. By making use of unique bioactive compounds with pharma-grade efficacy, Zaluvida is a pioneer in therapies and technologies for obesity, antibiotic resistance and for the reduction of greenhouse gas emissions. Our team is united by the desire to use visionary biotech innovations to support as many people as possible in shaping a better future for themselves. For further information visit: www.zaluvida.com.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/dd19e9b3-ce69-499e-a731-57a2a0142666
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/17143534-29ff-4560-b87c-847ad4f54d4b
Cami Rozanas Zaluvida North America 801-703-2361 [email protected]
